Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: January 2013

Cytori Therapeutics Inc. (CYTX) Starts Presentation at the Biotech Showcase 2013 Conference

Posted on January 8, 2013 by Mission IR

Cytori Therapeutics is a medical technologies company focused on the potential of adult stem cell and regenerative cells from adipose tissue. The company’s Celution® System family of medical devices and instruments is being sold into the European and Asian cosmetic … Continue reading →

Posted in EBD Group Conference | Leave a comment

Sucampo Pharmaceuticals (SCMP) Starts Presentation at the Biotech Showcase 2013 Conference

Posted on January 8, 2013 by Mission IR

Sucampo Pharmaceuticals is a global pharmaceutical company engaged in the development and commercialization of medicines based on prostones, a class of compounds occurring naturally in the body. The company is focused on developing prostone-based compounds for the treatment of gastrointestinal, … Continue reading →

Posted in EBD Group Conference | Leave a comment

DARA BioSciences, Inc. (DARA) Starts Presentation at the OneMedForum 2013 Conference

Posted on January 8, 2013 by Mission IR

DARA BioSciences is a specialty pharmaceutical company engaged in developing and commercializing oncology treatment and supportive care products. Through agreements with various entities, the company has comprehensive commercial coverage across the national oncology market. DARA is part of an integrated … Continue reading →

Posted in OneMedForum Conference | Leave a comment

Immunovaccine, Inc. (IMV) Starts Presentation at the OneMedForum 2013 Conference

Posted on January 8, 2013 by Mission IR

Immunovaccine is a clinical-stage vaccine development company focused on the advancement of its patented DepoVax vaccine adjuvanting platform and product candidates for cancer therapy, infectious disease and animal health. Demonstrating safety and immunogenicity potential, Immunovaccine has advanced its platform technology … Continue reading →

Posted in OneMedForum Conference | Leave a comment

Bio-Path Holdings Inc. (BPTH) Starts Presentation at the Biotech Showcase 2013 Conference

Posted on January 8, 2013 by Mission IR

Bio-Path Holdings is a biotech company focused on developing therapeutic products utilizing its proprietary liposomal delivery technology, which was designed to systemically distribute nucleic acid drugs throughout the human body via intravenous infusion. BPTH is primarily focused on cancer; its … Continue reading →

Posted in EBD Group Conference | Leave a comment

CytoSorbents Corporation (CTSO) Starts Presentation at the OneMedForum 2013 Conference

Posted on January 8, 2013 by Mission IR

CytoSorbents is a therapeutic device company focused on critical care. The company uses blood purification to modulate the immune system and fight multi-organ failure in life-threatening illnesses. CytoSorbents’ purification technology is based on biocompatible, highly porous polymer beads that are … Continue reading →

Posted in OneMedForum Conference | Leave a comment

ReNeuron Group (RNUGF) Starts Presentation at the Biotech Showcase 2013 Conference

Posted on January 8, 2013 by Mission IR

ReNeuron Group is engaged in the research, development and commercial exploitation of stem cell technologies for therapeutic and non-therapeutic applications worldwide. Its lead therapeutic candidate is ReN001 stem cell therapy, which is in clinical development stage for the treatment of … Continue reading →

Posted in EBD Group Conference | Leave a comment

Inovio Pharmaceuticals Inc. (INO) Starts Presentation at the Biotech Showcase 2013 Conference

Posted on January 8, 2013 by Mission IR

Inovio Pharmaceuticals is engaged in the development of synthetic vaccines, with a focus on cancers and infectious diseases. The company’s SynCon technology enables the design of universal vaccines capable of providing cross-protection against pathogens, such as influenza and human immunodeficiency … Continue reading →

Posted in EBD Group Conference | Leave a comment

FluoroPharma Medical, Inc. (FPMI) Starts Presentation at the OneMedForum 2013 Conference

Posted on January 8, 2013 by Mission IR

FluoroPharma Medical is a biopharmaceutical company focused on discovering and developing proprietary PET imaging and products for the evaluation of cardiac disease at the cellular and molecular levels. With licensed technology from the Massachusetts General Hospital in Boston, the company’s … Continue reading →

Posted in OneMedForum Conference | Leave a comment

Advanced Cell Technology Inc. (ACTC) Starts Presentation at the Biotech Showcase 2013 Conference

Posted on January 8, 2013 by Mission IR

Advanced Cell Technology is a biotech company that applies stem cell-based technologies (both adult and human embryonic) and other proprietary methods in the field of regenerative medicine. ACTC is also developing therapeutic platforms using corneal endothelial cells for use in … Continue reading →

Posted in EBD Group Conference | Leave a comment